Zygomatic and Oncology Dental Implants
The longer lengths and 55° restorative platform of Zygomatic and Oncology implants, in the treatment of patients with a severely resorbed maxilla and/or missing maxillary bone, enables zygomatic bone to be utilised and ensures optimal restorative platform emergence.
Following traumatic accidents, oncology resections or congenital defects, patients present with missing sections of bone and connecting soft tissue. These situations can pose significant physical and psychological effects on the patient.
55° Zygomatic Implants were introduced by Southern Implants in 2002 to accommodate a higher angle for the restorative table to be in the arch and not the palate providing prosthetic versatility.
More recently, Southern Implants expanded the 55° Zygomatic Implant range with the Oncology Implant and Zygan™ Implant.
The Oncology Implant has a a 15mm threaded apex and a coronal machined surface that can be exposed to soft tissue in oncology resections.
The Zygan Implant features a Narrow-Apex with a smooth mid-section and MSc threaded coronal region. This implant is especially useful in patients with smaller anatomies.
- 55° optimizes prosthetic versatility
- Machined sections for exposed soft tissue and decreased rotations
- Narrow Apex Available for smaller patients and easier placement
- External Hex connection with 2.7 width and .7 height
- 55° angle correction
- Zygomatic available in 35mm-60mm
- Oncology available from 27.5mm-47.5mm
- Zygan has a 2.8mm apex
- 4.0mm prosthetics
Boyes-Varley JG, Howes DG, Lownie JF, Blackbeard GA. Surgical Modifications to the Brånemark Zygomaticus Protocol in the Treatment of the Severely Resorbed Maxilla: A Clinical Report. Int J Oral Maxillofac Implants. 2003;18:232-237.
Boyes-Varley JG, Howes DG, Davidge-Pitts KD, Brånemark PI, McAlpine JA. A Protocol for Maxillary Reconstruction Following Oncology Resection Using Zygomatic Implants. Int J Prosthodont 2007;20:521-531.
Boyes-Varley JG, Howes DG. The Zygomaticus Implant Protocol in the treatment of the severely resorbed maxilla. SADJ. 2003, Vol 58(3).
Chrcanovic BR, Albrektsson T, Wennerberg A. Survival and complications of zygomatic implants: an updated systematic review, Journal of Oral and Maxillofacial Surgery (2016), doi: 10.1016/j.joms.2016.06.166.
Dattani A, Richardson D, Butterworth CJ. A novel report on the use of oncology zygomatic implant-retained maxillary obturator in a paediatric patient. International Journal of Implant Dentistry (2017) 3:9 DOI 10.1186/s40729-017-0073-7.
Pellegrino G, Basile F, Richieri L, Tarsitano A, Marchetti C. Large defect rehabilitation of upper jaw with zygomatic/oncologic implants. Preliminary results of a prospective study. Clin. Oral Impl. 2014, Res. 25 (Suppl. 10).
Pellegrino G, Tarsitano A, Basile F, Pizzigallo A, Marchetti C. Computer-Aided Rehabilitation of Maxillary Oncological Defects Using Zygomatic Implants: A Defect-Based Classiﬁcation. American Association of Oral and Maxillofacial Surgeons, 2015, 0278-2391/15/01265-3.
For further detailed information about Zygomatic and Oncology implants, please see the documents made available for your reference.
Zygomatic Surgical Manual
Osseointegrated implants are now an indispensable part of prosthetic rehabilitation options. With the globalization of medical infrastructures and higher standards of living, implant applications continue to increase…